Trials / Conditions / Postprandial Hypoglycemia

Postprandial Hypoglycemia

11 registered clinical trials studyying Postprandial Hypoglycemia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Canakinumab for the Treatment of Postprandial Hypoglycemia NCT05401578	University Hospital, Basel, Switzerland	Phase 3
Completed	Glucose Response to a Formula for Patients at Risk of Hypoglycaemia NCT05676385	Nutricia Research	N/A
Completed	The Scottish Fruit Study NCT05513404	University of Aberdeen	N/A
Withdrawn	Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes NCT05174507	University Hospital, Basel, Switzerland	Phase 2
Terminated	Empagliflozin for the Treatment of Postprandial Hypoglycemia NCT05036317	University Hospital, Basel, Switzerland	Phase 3
Completed	Treatment of Post-bariatric Hypoglycaemia NCT04836273	Filip Krag Knop	Phase 2
Completed	Effect of Postprandial Hyperinsulinaemic Hypoglycaemia on Driving Performance. NCT04330196	Lia Bally	N/A
Completed	Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass NCT03984370	University Hospital, Gentofte, Copenhagen	Phase 2
Unknown	Canagliflozin in Postprandial Hyperinsulinemic Hypoglycemia (CANA-PHH-RYGB) NCT04720859	Hospital Universitari Vall d'Hebron Research Institute	N/A
Completed	Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR- NCT03200782	University Hospital, Basel, Switzerland	N/A
Completed	Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia NCT01162499	Diva De Leon	N/A